US$ 20.35
sglt2 inhibitors and glp 1 receptor agonists Effect of combination treatment with glucagon-like peptide-1 sodium-glucose cotransporter-2 on incidence of cardiovascular and serious renal events: population based cohort study GLP-1 Receptor Agonists | New
Description
exploration of individual microbiome profiling to enable personalized probiotic selection based on baseline gut bacteria composition

Our results showed that allulose mitigated the adverse effects of high-fat, high-sugar diets, including reduced body weight gain and improved insulin resistance

50 It can increase satisfaction derived from smaller amounts of food and help differentiate between physical hunger and emotional eating triggers

Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression

Over the next several years, as more innovative therapies enter clinical development and commercialization, the GLP-1 field is expected to maintain rapid growth while expanding into broader metabolic disease management

Food and Drug Administration (FDA) for this indication